Please provide your email address to receive an email when new articles are posted on . Delayed presentation of 24 hours or more after non-STEMI symptom onset was associated with greater risk for ...

PARIS, France—Among patients with acute MI and occlusive disease on invasive angiography, those presenting without ST-segment elevation on the initial ECG fare worse than those with STEMI, researchers ...

Women are more likely than men to develop heart failure (HF) both during and after STEMI and are also more likely to die, according to a large Canadian study. The increased risk was not seen among ...

Complete rather than culprit-only revascularization appears to pay off long-term for patients with multivessel disease presenting with non-ST-segment elevation MI (NSTEMI), suggests an observational ...

Sophia Antipolis, 19 Nov. 2015: Thrombus aspiration before percutaneous coronary intervention (PCI) does not improve 12-month clinical outcomes in patients with non-ST-elevation myocardial infarction ...

Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...

New challenges can lead to new rules, or at least new protocols based on the best available data. The president of the Society for Cardiovascular Angiography and Interventions (SCAI) recently ...

(HealthDay News) — For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), beta-blocker therapy at discharge correlates with ...

Despite overall improvements to care for a heart attack, women are less likely to receive timely treatment, according to a new study in Annals of Emergency Medicine. Heart attack treatments have come ...

Although active cancer is recognised as a risk factor for increased bleeding, the specific bleeding risks associated with ...